Myasthenia Gravis Disease Market

Myasthenia gravis (MG) is a long-term neuromuscular disease that leads to varying degrees of skeletal muscle weakness. The most commonly affected muscles are those of the eyes, face, and swallowing. It can result in double vision, drooping eyelids, trouble talking, and trouble walking. Onset can be sudden. Those affected often have a large thymus gland or develop a thymoma.
Myasthenia Gravis Disease Market aims to provide a comprehensive presentation of the global market for Myasthenia Gravis Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myasthenia Gravis Disease. Myasthenia Gravis Disease Market contains market size and forecasts of Myasthenia Gravis Disease in global, including the following market information:
Global Myasthenia Gravis Disease Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Myasthenia Gravis Disease market was valued at US$ 979 million in 2022 and is projected to reach US$ 1703.1 million by 2029, at a CAGR of 8.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Myasthenia gravis is generally treated with medications known as acetylcholinesterase inhibitors such as neostigmineand pyridostigmine. Immunosuppressants, such as prednisone or azathioprine, may also be used. The surgical removal of the thymus gland may improve symptoms in certain cases. Plasmapheresis and high dose intravenous immunoglobulin may be used during sudden flares of the condition. If the breathing muscles become significantly weak, mechanical ventilation may be required.
We surveyed the Myasthenia Gravis Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Myasthenia Gravis Disease Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Myasthenia Gravis Disease Market Segment Percentages, by Type, 2022 (%)
Medication
Surgery
Hematopoietic Stem Cell Transplantation (HSCT)
Other
Global Myasthenia Gravis Disease Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Myasthenia Gravis Disease Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Academic Research Institutes
Global Myasthenia Gravis Disease Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Myasthenia Gravis Disease Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Myasthenia Gravis Disease revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Myasthenia Gravis Disease revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health
Sun Pharmaceuticals Industries
Novartis Pharmaceuticals
Teva Pharmaceutical Industries
Cipla
Roche
Apotex Corporation
Pfizer
Bristol-Myers And Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Myasthenia Gravis Disease, market overview.
Chapter 2: Global Myasthenia Gravis Disease market size in revenue.
Chapter 3: Detailed analysis of Myasthenia Gravis Disease company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Myasthenia Gravis Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.